DUBLIN--(BUSINESS WIRE)--Jul 5, 2018--The "Europe Erectile Dysfunction Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

This research provides insights into Erectile Dysfunction epidemiology, Erectile Dysfunction diagnosed patients, and Erectile Dysfunction treatment rate for EU5 countries. The research measures key indicators including prevalence of Erectile Dysfunction derived from epidemiological analysis, patients diagnosed with Erectile Dysfunction, and patients treated with a drug therapy.

The research study helps executives estimate Erectile Dysfunction market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Erectile Dysfunction prevalence, Erectile Dysfunction diagnosis rate, and Erectile Dysfunction treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Erectile Dysfunction: Disease Definition

2. Erectile Dysfunction Patient Flow in Europe

2A. Erectile Dysfunction Prevalence in Europe

2B. Erectile Dysfunction Diagnosed Patients in Europe

2C. Erectile Dysfunction Treated Patients in Europe

3. Erectile Dysfunction Patient Flow in Germany

3A. Erectile Dysfunction Prevalence in Germany

3B. Erectile Dysfunction Diagnosed Patients in Germany

3C. Erectile Dysfunction Treated Patients in Germany

4. Erectile Dysfunction Patient Flow in France

4A. Erectile Dysfunction Prevalence in France

4B. Erectile Dysfunction Diagnosed Patients in France

4C. Erectile Dysfunction Treated Patients in France

5. Erectile Dysfunction Patient Flow in Spain

5A. Erectile Dysfunction Prevalence in Spain

5B. Erectile Dysfunction Diagnosed Patients in Spain

5C. Erectile Dysfunction Treated Patients in Spain

6. Erectile Dysfunction Patient Flow in Italy

6A. Erectile Dysfunction Prevalence in Italy

6B. Erectile Dysfunction Diagnosed Patients in Italy

6C. Erectile Dysfunction Treated Patients in Italy

7. Erectile Dysfunction Patient Flow in UK

7A. Erectile Dysfunction Prevalence in UK

7B. Erectile Dysfunction Diagnosed Patients in UK

7C. Erectile Dysfunction Treated Patients in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/nccdsp/erectile?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180705005515/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Sexual and Reproductive Health Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/05/2018 02:25 PM/DISC: 07/05/2018 02:25 PM

http://www.businesswire.com/news/home/20180705005515/en